Bharat Bio successfully completes Phase III trials of new oral...

Dununu.com Dununu

Sponsorluk

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

RSS Feed National

Posted

98

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

Please log in to like, share and comment!

Nepal Telecom’s profit falls nearly 49%, raising concerns over 5G rollout

KATHMANDU: State-owned Nepal Telecom (NT) has reported a sharp drop of 48.67 percent in its net...

By 0 0

Donald Trump to host private dinner for top crypto investors in his memecoin

Donald Trump is hosting a dinner for top investors in his $TRUMP memecoin, including Justin Sun,...

By 0 10

Dr. Baburam’s secretariat hits back at Prachanda

KATHMANDU: Rekhi Gurung, personal aide to former Prime Minister and Nepal Samajwadi Party (Naya...

By 0 14

EĞİTİM BİLGİLERİ

BPSC ASO Recruitment 2025: Notification released at bpsc.bihar.gov.in, registration begins on this date

By 0 15

Dhanush to play former President Dr APJ Abdul Kalam in Om Raut’s biopic

MUMBAI: Actor Dhanush is all set to portray the Missile Man of India and the 11th President, Dr...

By 0 19